ArticleMaterials (Basel, Switzerland)2025
GCN-Based Framework for Materials Screening and Phase Identification.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study proposes a novel framework using graph convolutional networks to analyze and interpret X-ray diffraction patterns, addressing challenges in phase identification for multi-phase materials. By representing X-ray diffraction patterns as graphs, the framework captures both local and global relationships between diffraction peaks, enabling accurate phase identification even in the presence of overlapping peaks and noisy data. The framework outperforms traditional machine learning models, achieving a precision of 0.990 and a recall of 0.872. This performance is attained with minimal hyperparameter tuning, making it scalable for large-scale material discovery applications. Data augmentation, including synthetic data generation and noise injection, enhances the model's robustness by simulating real-world experimental variations. However, the model's reliance on synthetic data and the computational cost of graph construction and inference remain limitations. Future work will focus on integrating real experimental data, optimizing computational efficiency, and exploring lightweight architectures to improve scalability for high-throughput applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.